News

New Genomic Tests to Diagnose Deadly Infections Faster

By Andrew Jacobs on February 24, 2020
Rapid genomic tests are poised to change the way doctors diagnose and treat infections. Read

Precision medicine at UCSF

By Sean Karlin on February 04, 2020
Dr. Michael Lesh participated in the panel discussion “Medical Imaging for a Precision Medicine Future” at the 2020 Precision Medicine World Conference. Password: pmwc2020 (case sensitive). Watch Here

Digital Health Wins Big at UCSF Awards Event

By Bar Cudkevich on October 15, 2019
Anne Wojcicki (23 and Me), Glen Tullman (Livongo), and Sean Duffy (Omada Health) inaugurate the UCSF Digital Health Innovation Hall of Fame.

InVest In Ourselves...

October 02, 2019
The UCSF InVent Fund is open for business! Innovation Ventures supports faculty whose inventions would benefit from licensing to new or established companies with the expertise and funding to develop those further.

From the Lab to the Bedside

October 01, 2019
Join UCSF’s Entrepreneurs in Residence (EIRs) and provide valuable expertise to UCSF’s most promising ideas. More Information to come.

University of California Announces Collaboration with Janssen to Expand Data Science Research in Healthcare

By Laura Kurtzman on June 28, 2019
New fellowship program facilitated by Johnson & Johnson Innovation to recruit data scientists for high-impact, data-driven healthcare research

UC Announces Collaboration in Data Science Research

By Laura Kurtzman on June 28, 2019
New fellowship program facilitated by Johnson & Johnson with UCSF and UC Berkeley to recruit data scientists for data-driven healthcare research.

Clinical Metagenomic Sequencing for Diagnosis of Meningitis and Encephalitis

By Charles Chiu MD, PhD on June 14, 2019
BACKGROUND Metagenomic next-generation sequencing (NGS) of cerebrospinal fluid (CSF) has the potential to identify a broad range of pathogens in a single test.

GlaxoSmithKline taps UC’s CRISPR expertise to speed drug discovery

By Public Affairs, UC Berkeley on June 13, 2019
Jennifer Doudna and Jonathan Weissman are the key players in a new collaboration with GlaxoSmithKline to apply CRISPR techniques to the discovery of new drug targets, potentially leading to new therapies for genetic diseases.

Pages